SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRKs sharp rally has traders focused on Starknets privacy and Bitcoin DeFi plans, alongside its STARK-based post-quantum security narrative. Bullish momentum and ecosystem optimism are tempered by concerns about token unlocks, selling pressure, and whether the move is a short-lived pump.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

TAO is drawing attention amid a recent price rebound, with traders debating whether the move can continue or give way to another pullback. Bulls point to Bittensors decentralized-AI ecosystem and subnet development, while cautious voices question adoption and near-term catalysts amid broader crypto and macro uncertainty.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillows steep selloff is being tied to a weak housing markethigh mortgage rates and affordability pressures are weighing on transactionswith lowered guidance adding to concerns despite revenue growth. Bearish traders see further downside, while bulls argue the shares are oversold and point to growth in rentals, mortgages and AI-enabled products.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Attention centers on Compounds institutional-market push, including a reported launch, new leadership and investment plans, alongside anticipation for V4. Many traders are bullish on COMPs limited supply and potential breakout, while skeptics point to weak relative price action and concerns about protocol liquidity.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is drawing attention after a recent rise in trading activity, with traders comparing the companys Niemann-Pick franchise to IntraBios reported acquisition and arguing that Zevra may be undervalued; some speculate about a potential buyer, but no deal is confirmed. The discussion also points to the pending European re-examination and upcoming results, with views divided over regulatory prospects and the stocks gains.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEARs rally is being tied to the launch of confidential perpetual trading powered by Hyperliquid, with traders also highlighting the tokens AI-agent and cross-chain Intents narrative. The reaction is largely bullish, though some remain cautious about pullbacks and the earlier NEAR Intents exploit.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

A Brazilian federal appeals court restored Sigma Lithiums existing mining licenses, allowing operations to resume after a shutdown. Traders welcomed the restart, while noting that the plant expansion remains blocked pending a community-related survey, leaving legal and execution risks in focus.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins rebound and consolidation are driving IBIT discussion, with many traders treating pullbacks as buying opportunities and anticipating further gains, while others warn that momentum could fade. The conversation is largely about Bitcoins direction rather than a confirmed IBIT-specific catalyst.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

Gold miners are drawing attention as traders assess whether GDXs correction is bottoming, with higher real yields and a stronger dollar cited as near-term pressure on gold and miners. Some see signs of a rebound and are buying dips, while others want confirmation and warn that the pullback may continue; longer-term bulls point to central-bank buying and concerns about debt and currency debasement.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

XCN is drawing attention amid a modest rebound and ongoing consolidation, with traders focused on chart levels, returning volume and the prospect of a breakout. Some are buying dips and expecting momentum to build, while others warn that thin volume and repeated rallies that fade make the move look like a pump-and-dump; broader crypto-market weakness is also cited.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharma feels supply pain despite duty relief

New Delhi: Maintaining a steady supply of essential petrochemical inputs amid the West Asia conflict remains a concern for India's pharmaceutical industry, even though the government has waived customs duties on several of these products until June 30, according to industry executives.They said that while the duty waiver provides some cost relief to the sector, the main challenge is securing supplies and ensuring their timely movement."The government's decision to waive duties on select petrochemical products demonstrates its commitment to standing by the pharma industry but the far bigger challenge lies in ensuring the supply and timely movement of these materials," said Mehul Shah, a pharma industry expert.Shah pointed out that Saudi chemical giant SABIC declaring force majeure on methanol and styrene validates the industry's supply concerns.The disruption to shipping at the Strait of Hormuz has hit production of chemicals globally, especially in West Asia and Asia.The government on Thursday announced a temporary waiver on customs duty on over 40 critical petrochemical products, including anhydrous ammonia, methanol, styrene and polymers like PVC and PET chips.Namit Joshi, chairman of Pharmaceuticals Export Promotion Council of India (Pharmexcil), said it the duty waiver will be helpful only if the exporting nations maintain their invoicing price. "Unfortunately, that is beyond our control.

Why Did Poly Medicure Shares Crash 44% Despite Strong Long Term Growth?

Synopsis: Poly Medicure, with a market cap of ₹16,077 cr and 14 global manufacturing facilities, saw its stock fall ~44% due to moderated revenue growth of 5–6% in H1FY26. Strategic acquisitions and India–EU trade deal opportunities position it for 15–16% full-year growth. Poly Medicure, a key player in India’s medical devices sector, has recently faced significant […] The post Why Did Poly Medicure Shares Crash 44% Despite Strong Long Term Growth? appeared first on Trade Brains .

Buyer Not A Consumer If Purchase Made For Profit: SC

File Photo Of Supreme Court Of India New Delhi- In a significant verdict, the Supreme Court on Thursday held that if any purchase of goods or services is for profit generation, then the purchaser cannot be held to be a consumer and consequently cannot pursue cases under the Consumer Protection Act. A bench of Justices JB Pardiwala and Manoj Misra, delivering the judgement in an appeal filed by M/s Poly Medicure Ltd, affirmed the findings of the State and National Consumer Disputes Redressal Commissions that the complaint filed by the company was not maintainable under the Act. It held that a company purchasing software to automate its business processes cannot be regarded as a “consumer” under the Consumer Protection Act, 1986, as such a transaction is for a “commercial purpose”. Authoring the verdict, Justice Manoj Misra referred to various judgements and said, “the transaction of purchase of goods/ services (i.e., software) had a nexus with generation of profits and, therefore, qua that transaction the appellant cannot be considered a consumer as defined in Section 2(1)(d) of the 1986 Act.” If the transaction has a nexus with generation of profits, it would be treated as one for a commercial purpose, it said while dismissing the appeal of the firm.

Stocks to buy: Nagaraj Shetti recommends Poly Medicure, Oil India shares to buy

India's stock market remained stable after four days of losses, with Nifty 50 down 0.29% and BSE Sensex down 0.33%. Investor confidence was affected by U.S. visa fee hikes, foreign selling, and tariffs. Experts suggest cautious optimism for recovery in the IT sector and private banks.

Poly Medicure Acquires Italian Orthopaedics Firm For ₹324 Crore

Equity

Poly Medicure’s shares closed 1.5% higher at ₹1,982 on Wednesday

Trading Radar For September 24: Swiggy, Akzo Nobel, Dilip Buildcon, Lemon Tree, Torrent Stocks Are On Investors’ Watchlist

Benchmark indices are set for a weak opening, tracking cues from Asian markets.

Top Breakout Stock Ideas: Analysts Pick Biocon, KFin Tech, Poly Medicure, Sammaan Capital And More

Stocks such as Elgi Equipment, Supriya Life and Bajaj Consumer are on the breakout radar with upside potential, say analysts. 


Healthcare Stocks Get A GST Boost: Index Nears Breakout; Bull Run Likely In Apollo, Fortis, Dr Lal, Poly Medicure 

The analyst said the GST cut expands access to care while opening steady opportunities for companies in the sector.

Trading Radar For August 21: Vedanta, Zee Entertainment, Clean Science, India Cements, Railtel Are On Stocks Watchlist

Gem Aromatics, Patel Retail, Shreeji Shipping Global, Vikram Solar, and Mangal Electrical Industries IPOs are currently open for subscription

Solo-Dex And Polymedicure Partner To Bring Opioid-Free Acute Pain Management To India And Major Asian Markets

(MENAFN - ACCESSWIRE) NEW DELHI, INDIA AND WOLF CREEK, MT / ACCESS Newswire / August 6, 2025 / Solo-Dex, Inc., a U.S.-based medical device innovator, and Poly Medicure Ltd. (Polymed), India's ...

Poly Medicure Ltd. engages in the manufacture and sales of medical devices. Its products are used in infusion therapy, central venous access catheters, blood management, urology, dialysis, diagnostics, and pediatrics. The company was founded by Jugal Kishore Baid on March 30, 1995, and is headquartered in New Delhi, India.

Current Price	1,594.50
Prev Close	1,617.90
Open	1,596.00
Dividend Yield	0.29%
50-Day Moving Average	1,716.49
Beta	0.02
Avg. Volume	146,740.24
PE Ratio	51.06

52-Week High	2,094.30
52-Week Low	1,182.00
Market Capitalization	160.7B
EPS (Annual)	31.79
Price to Book	5.18
Revenue Per Employee	7.12M

Feed

News

Sentiment

Fundamentals

Info

POLYMED.NSE Fundamentals